For instance, pharmacological activation of AdipoR1/2 as nicely ilustrated in8,15 could be exploited to treat pathologies that correlate with abnormally elevated levels of SFA in phospholipids and membrane properties changes, such as diabetes (reviewed in59). This evidence concerns the gene ADIPOR1 and diabetes mellitus.